Find uplifting stories about heroes, innovations, and solutions
864 results for "mrna vaccine"
The FDA reversed its decision and will now review Moderna's groundbreaking mRNA flu vaccine, marking a potential leap forward in flu prevention. This could bring the same technology that revolutionized COVID vaccines to seasonal flu shots.
A groundbreaking trial shows Moderna's new mRNA flu vaccine is 27% more effective than traditional flu shots, offering hope for better protection during flu season. The technology's faster production could mean vaccines that better match circulating strains.
Mexico signed a groundbreaking agreement with Moderna to manufacture mRNA vaccines domestically, including potential vaccines for dengue and cancer. The five-year partnership will transfer cutting-edge vaccine technology to Mexican facilities and support local scientific research.
mRNA vaccines prevented eight million COVID infections in their first six months and now show promise for treating cancer. Despite recent political setbacks, scientists remain confident this breakthrough technology will transform medicine.
The FDA suddenly agreed to review Moderna's revolutionary mRNA flu vaccine after initially rejecting it just a week earlier. Meanwhile, scientists developed an inhaled vaccine that could protect against multiple respiratory illnesses at once.
Scientists have cracked a major puzzle in malaria prevention using mRNA vaccine technology to overcome a natural barrier that weakened previous vaccines. The breakthrough could transform protection against a disease that still causes hundreds of millions of infections each year.
A groundbreaking study shows personalized mRNA vaccines combined with immunotherapy kept nearly 70% of melanoma patients cancer-free after five years, compared to just 49% with immunotherapy alone. The same technology that powered COVID-19 vaccines is now transforming how we fight cancer.
Scientists are testing an mRNA vaccine that could be ready before a bird flu pandemic ever starts. Unlike COVID-19, this time we'd have protection waiting on the shelf.
After rejecting Moderna's flu vaccine application just a week ago, the FDA reversed course and will now review the promising mRNA shot. The new technology could revolutionize how we protect ourselves from seasonal flu.
Scientists at Harvard have created a new DNA origami vaccine that works as well as mRNA shots but doesn't need freezers and is simpler to manufacture. The breakthrough could make life-saving vaccines accessible to millions more people worldwide.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
Britain just approved its first domestically manufactured mRNA vaccine, marking a major milestone in pandemic preparedness. The new Moderna facility in Oxfordshire can produce up to 250 million doses per year during health emergencies.
Scientists at MIT have developed a revolutionary cancer vaccine that completely eliminated tumors in most test mice by supercharging the body's T cells. The breakthrough could transform how we fight cancer and infectious diseases.
Moderna has agreed to pay Roivant up to $2.25 billion to settle a patent lawsuit over its groundbreaking Covid-19 vaccine technology. The settlement could become one of the largest in patent history while keeping life-saving vaccine innovation moving forward.
Scientists in the UK and US have started testing a new bird flu vaccine on 4,000 people, taking a proactive step to prepare for potential future pandemics. The vaccine uses the same mRNA technology that proved successful with COVID-19 shots.
A personalized mRNA cancer vaccine combined with immunotherapy reduced the risk of deadly skin cancer returning by nearly 50% over five years. The breakthrough treatment is now entering final-stage trials while researchers test similar vaccines for lung, bladder, and kidney cancers.
A personalized mRNA vaccine combined with immunotherapy stopped melanoma from returning in 69% of patients over five years, nearly double the rate of standard treatment alone. The breakthrough could transform how doctors fight not just skin cancer, but many other cancers too.
A personalized mRNA vaccine from Moderna and Merck has shown remarkable five-year results against aggressive skin cancer. The therapy nearly halves the risk of melanoma returning after surgery.
A groundbreaking mRNA therapy reduced melanoma recurrence or death by 49% over five years when combined with immunotherapy. The personalized vaccine teaches patients' immune systems to recognize and attack their specific cancer cells.
A personalized mRNA vaccine combined with immunotherapy reduced melanoma recurrence or death by nearly half over five years. The breakthrough treatment, developed by Merck and Moderna, teaches the immune system to recognize and attack cancer cells.
Showing 20 of 864